Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6348340rdf:typepubmed:Citationlld:pubmed
pubmed-article:6348340lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:6348340lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:6348340lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:6348340lifeskim:mentionsumls-concept:C0055000lld:lifeskim
pubmed-article:6348340lifeskim:mentionsumls-concept:C1521738lld:lifeskim
pubmed-article:6348340lifeskim:mentionsumls-concept:C0144299lld:lifeskim
pubmed-article:6348340pubmed:issue4lld:pubmed
pubmed-article:6348340pubmed:dateCreated1983-9-23lld:pubmed
pubmed-article:6348340pubmed:abstractTextT-1982 (cefbuperazone) was given intravenously to 21 children with the following acute bacterial infections; 13 cases of bronchopneumonia, 2 cases of urinary tract infection, 1 case of subcutaneous abscess, 1 case of cervical purulent lymphadenitis and acute tonsillitis, and 4 cases of acute bronchitis. Clinical effectiveness was obtained in 20 cases out of 21 cases and bacteriological effectiveness in 7 cases out of 8 cases. As for the side effects, 1 patient had asymptomatic eosinophilia, but no other laboratory abnormalities were observed. Above results suggest that T-1982 is a useful antibiotic for treating pediatric patients with various kinds of bacterial infections.lld:pubmed
pubmed-article:6348340pubmed:languagejpnlld:pubmed
pubmed-article:6348340pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6348340pubmed:citationSubsetIMlld:pubmed
pubmed-article:6348340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6348340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6348340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6348340pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6348340pubmed:statusMEDLINElld:pubmed
pubmed-article:6348340pubmed:monthAprlld:pubmed
pubmed-article:6348340pubmed:issn0368-2781lld:pubmed
pubmed-article:6348340pubmed:authorpubmed-author:OkamotoTTlld:pubmed
pubmed-article:6348340pubmed:authorpubmed-author:OharaKKlld:pubmed
pubmed-article:6348340pubmed:authorpubmed-author:MiyauchiYYlld:pubmed
pubmed-article:6348340pubmed:authorpubmed-author:AsanoEElld:pubmed
pubmed-article:6348340pubmed:authorpubmed-author:NishimoriMMlld:pubmed
pubmed-article:6348340pubmed:authorpubmed-author:SakaguchiZZlld:pubmed
pubmed-article:6348340pubmed:issnTypePrintlld:pubmed
pubmed-article:6348340pubmed:volume36lld:pubmed
pubmed-article:6348340pubmed:ownerNLMlld:pubmed
pubmed-article:6348340pubmed:authorsCompleteYlld:pubmed
pubmed-article:6348340pubmed:pagination855-61lld:pubmed
pubmed-article:6348340pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:meshHeadingpubmed-meshheading:6348340-...lld:pubmed
pubmed-article:6348340pubmed:year1983lld:pubmed
pubmed-article:6348340pubmed:articleTitle[Clinical experience with T-1982 (cefbuperazone) in the pediatric field].lld:pubmed
pubmed-article:6348340pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6348340pubmed:publicationTypeEnglish Abstractlld:pubmed